The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Therapeutical use of probiotic formulations in clinical practice
Open accessAbstract
Background & Aims The spreading of gastrointestinal diseases is growing all over the world. Although for some of them an effective therapeutic approach has been found, palliation rather than cure is very frequent due to a partial knowledge of their aethiology and pathogenesis. This review, analyzing the main clinical studies, aims at being a state of the art update of the use of probiotic formulations in daily practice. Methods In this review we include all the most significant clinical trials involving the use of probiotic formulations for the treatment of several pathologies. Results Dysbiosis has been observed in irritable bowel syndrome patients. Probiotics may exert a beneficial effect on Crohn’s disease affected patients who have shown gut microbiota antigens and altered wall permeability. Moreover some probiotic formulations seem to enhance the therapy for Helycobacter Pylori reducing its pathogenic potential. Intestinal ecology imbalance has been also linked to cancer induction, allergy, skin and urogenital diseases. In addition probiotics administration seems to be particularly useful to ease post-operative complications. Conclusion Further future clinical trials, involving large numbers of patients, will be mandatory to achieve definite evidence of the preventive and curative role of probiotics in medical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics
Gibson, G. R., & Roberfroid, M. B. (1995) · The Journal of Nutrition · doi:10.1093/jn/125.6.1401 · Cited by 7,667
The gut microbiota shapes intestinal immune responses during health and disease
Round, J. L., & Mazmanian, S. K. (2009) · Nature Reviews Immunology · doi:10.1038/nri2515 · Cited by 5,029
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413
Fitzgerald, M., Hayward, I. P., Thomas, A. C., Campbell, J. H., & CAMPBELL, G. R. (1995) · Cited by 2,552
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
Microbes in Gastrointestinal Health and Disease
Neish, A. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.080 · Cited by 1,386
Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut
Collins, M. D., & Gibson, G. R. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.5.1052s · Cited by 912
Whorwell, P. J., Altringer, L., Morel, J., Bond, Y., Charbonneau, D., O'Mahony, L., Kiely, B., Shanahan, F., & Quigley, E. M. M. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00734.x · Cited by 799
Kailasapathy, K., & Chin, J. (2000) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2000.00886.x · Cited by 779
Furrie, E., Macfarlane, S., Kennedy, A., Cummings, J. H., Walsh, S. V., O’Neil, D. A., & Macfarlane, G. T. (2005) · Gut · doi:10.1136/gut.2004.044834 · Cited by 766 · cited 1×
“88 used a synbiotc combining a probiotic, B. longum, isolated from healthy rectal epithelium, and a prebiotic (Synergy 1), a preferential inulin-oligofructose growth substrate for the probiotic strain to treat UC patients.”
Method
Cited by
Intestinal microbiota in human health and disease: the impact of probiotics
Gerritsen, J., Smidt, H., Rijkers, G. T., & de Vos, W. M. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0229-7 · Cited by 724
Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health
Parker, A., Fonseca, S., & Carding, S. R. (2020) · Gut Microbes · doi:10.1080/19490976.2019.1638722 · Cited by 702
Lyte, M. (2011) · BioEssays · doi:10.1002/bies.201100024 · Cited by 549
The role of lactobacilli and probiotics in maintaining vaginal health
Borges, S., Silva, J., & Teixeira, P. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-013-3064-9 · Cited by 397
Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer
Raman, M., Ambalam, P., Kondepudi, K. K., Pithva, S., Kothari, C., Patel, A. T., Purama, R. K., Dave, J. M., & Vyas, B. R. M. (2013) · Gut Microbes · doi:10.4161/gmic.23919 · Cited by 268
The Battle of Probiotics and Their Derivatives Against Biofilms
Barzegari, A., Kheyrolahzadeh, K., Hosseiniyan Khatibi, S. M., Sharifi, S., Memar, M. Y., & Zununi Vahed, S. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s232982 · Cited by 263
“High-throughput approaches including transcriptomics, metabolomics, proteomics and metagenomics have revealed that probiotics present beneficial for the host and they canmodify host mucosal and systemic immune responses and protect the host against pathogens.(4) Lactobacillus (lactic Acid Bacteria, LAB) and Bifidobact…”
The use of probiotics as eco-friendly alternatives for antibiotics in poultry nutrition
Alagawany, M., Abd El-Hack, M. E., Farag, M. R., Sachan, S., Karthik, K., & Dhama, K. (2018) · Environmental Science and Pollution Research · doi:10.1007/s11356-018-1687-x · Cited by 253
A comprehensive review of probiotics and human health-current prospective and applications
Sarita, B., Samadhan, D., Hassan, M. Z., & Kovaleva, E. G. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1487641 · Cited by 250
Chidambaram, S. B., Essa, M. M., Rathipriya, A. G., Bishir, M., Ray, B., Mahalakshmi, A. M., Tousif, A. H., Sakharkar, M. K., Kashyap, R. S., Friedland, R. P., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107988 · Cited by 204
Nikbakht, E., Khalesi, S., Singh, I., Williams, L. T., West, N. P., & Colson, N. (2018) · European Journal of Nutrition · doi:10.1007/s00394-016-1300-3 · Cited by 126
Duytschaever, G., Huys, G., Bekaert, M., Boulanger, L., De Boeck, K., & Vandamme, P. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.05933-11 · Cited by 114
Influence of fermented milk products, prebiotics and probiotics on microbiota composition and health
Ceapa, C., Wopereis, H., Rezaïki, L., Kleerebezem, M., Knol, J., & Oozeer, R. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2013.04.004 · Cited by 98
“(IBD), irritable bowel syndrome (IBS), coeliac disease and infectious enterocolitis [70–73].”
BackgroundKarimi Ardestani, S., Tafvizi, F., & Tajabadi Ebrahimi, M. (2019) · Human & Experimental Toxicology · doi:10.1177/0960327119851255 · Cited by 82
Non-Melanoma Skin Cancer: news from microbiota research
Squarzanti, D. F., Zavattaro, E., Pizzimenti, S., Amoruso, A., Savoia, P., & Azzimonti, B. (2020) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2020.1794792 · Cited by 40
Metadata
- Authors
- Iannitti, T., & Palmieri, B.
- Venue
- Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2010-12
- Volume
- 29
- Issue
- 6
- Pages
- 701-725
- ISSN
- 0261-5614 (ISSN-L)
- OpenAlex
- W2082707689
- Cited by
- 260
- References
- 116
- FWCI
- 26.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.